Skip to content
No results
  • About Us
  • Contact Us
  • Disclaimer
  • Event Venues
  • Events and Conferences
  • Home
  • Organizer Dashboard
  • Organizer Dashboard
  • Privacy Policy
  • Submit Organizer Form
  • Submit Organizer Form
  • Submit Venue Form
  • Submit Venue Form
  • Subscribe
  • Terms and Conditions
  • Venue Dashboard
  • Venue Dashboard
  • About Us
  • Contact Us
The Pharma Data

  • News
  • Press Releases
  • Research
  • Business
  • Regulatory
  • Events and Conferences
The Pharma Data
  • Press Releases

WHO Unveils Online Training Series to Support Chemical Emergency Preparedness

  • The Pharma Data
  • June 7, 2025

WHO Advances Global Chemical Hazard Preparedness with New Comprehensive Online Training Series In a recent address to the Seventy-eighth World Health Assembly, Dr. Tedros Adhanom Ghebreyesus, Director-General of the World…

Read MoreWHO Unveils Online Training Series to Support Chemical Emergency Preparedness
  • NewsResearch

Otsuka’s Sibeprenlimab Shows Significant Proteinuria Reduction in Phase 3 IgAN Trial

  • The Pharma Data
  • June 7, 2025

Otsuka Unveils Promising Phase 3 Results for Sibeprenlimab in IgA Nephropathy, Marking Significant Proteinuria Reduction and Advancing a Novel APRIL-Targeted Therapy Otsuka Pharmaceutical Development & Commercialization, Inc., in collaboration with…

Read MoreOtsuka’s Sibeprenlimab Shows Significant Proteinuria Reduction in Phase 3 IgAN Trial
  • News

Vertex Highlights ALYFTREK® Data and Sweat Chloride Goals at European CF Conference

  • The Pharma Data
  • June 7, 2025

Vertex Showcases Robust Clinical Data Supporting ALYFTREK® and the Critical Role of Sweat Chloride Reduction at 2025 European Cystic Fibrosis Conference New findings reinforce the value of CFTR modulation and…

Read MoreVertex Highlights ALYFTREK® Data and Sweat Chloride Goals at European CF Conference
  • News

Sanofi Showcases Rare Disease Pipeline Innovations at ISTH

  • The Pharma Data
  • June 7, 2025

Sanofi Highlights Robust Pipeline of Innovations in Rare Blood Disorders at ISTH 2025 Sanofi is poised to take center stage at the 33rd Congress of the International Society on Thrombosis…

Read MoreSanofi Showcases Rare Disease Pipeline Innovations at ISTH
  • News

EU Approves Fixed-Duration Calquence Regimens for 1st-Line CLL

  • The Pharma Data
  • June 7, 2025

AstraZeneca’s Fixed-Duration Calquence Regimen Gains EU Approval for First-Line Treatment of Chronic Lymphocytic Leukaemia AstraZeneca has received European Union (EU) approval for a fixed-duration combination therapy using its Bruton’s tyrosine…

Read MoreEU Approves Fixed-Duration Calquence Regimens for 1st-Line CLL
  • News

Immunization at Every Stage of Life: A Key to Lifelong Health

  • The Pharma Data
  • June 6, 2025

A Life-Course Approach to Immunization: Prioritizing Vaccination at Every Age to Unlock the Full Potential of Lifelong Health In a striking demographic milestone, the global population is undergoing a historic…

Read MoreImmunization at Every Stage of Life: A Key to Lifelong Health
  • News

WHO Urges Protection for Gaza’s Nasser and Al-Amal Hospitals

  • The Pharma Data
  • June 6, 2025

WHO Sounds Alarm on Imminent Collapse of Gaza Health System as Nasser and Al-Amal Hospitals Face Shutdown The World Health Organization (WHO) has issued an urgent warning about the imminent…

Read MoreWHO Urges Protection for Gaza’s Nasser and Al-Amal Hospitals
  • News

Grifols Names Anne-Catherine Berner as New Board Chair

  • The Pharma Data
  • June 6, 2025

Anne-Catherine Berner Appointed as New Chair of Grifols: A Strategic Move Toward Long-Term Value Creation and Governance Excellence Grifols a global leader in the development of plasma-derived therapies and diagnostic…

Read MoreGrifols Names Anne-Catherine Berner as New Board Chair
  • News

Finerenone and SGLT2 Inhibitor Combo Shows Promise in CKD with Type 2 Diabetes

  • The Pharma Data
  • June 6, 2025

Bayer’s CONFIDENCE Study Demonstrates Promising Results for Simultaneous Use of Finerenone and Empagliflozin in Managing Chronic Kidney Disease in Type 2 Diabetes Bayer has announced compelling new clinical findings from…

Read MoreFinerenone and SGLT2 Inhibitor Combo Shows Promise in CKD with Type 2 Diabetes
  • News

Zoetis Highlights Environmental and Social Impact in 2024 Update

  • The Pharma Data
  • June 6, 2025

Zoetis Unveils 2024 Sustainability Progress Report, Showcasing Global Commitments to Communities, Animal Health, and the Planet Zoetis, a global leader in animal health, has released its 2024 Sustainability Progress Update,…

Read MoreZoetis Highlights Environmental and Social Impact in 2024 Update
  • News

Sanofi Launches 2025 Global Stock Plan for Employees

  • The Pharma Data
  • June 6, 2025

Sanofi Unveils 2025 Global Employee Shareholding Plan, Reinforcing Long-Term Workforce Commitment Sanofi has officially launched Action 2025, the latest installment of its long-running global employee shareholder program. Opening on June…

Read MoreSanofi Launches 2025 Global Stock Plan for Employees
  • News

Vividion and Bayer Advance Oncology Pipeline with WRN Inhibitor

  • The Pharma Data
  • June 5, 2025

Vividion and Bayer Expand Oncology Pipeline with Exclusive Rights to Clinical-Stage WRN Inhibitor VVD-214 Vividion Therapeutics,a clinical-stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, has announced a significant…

Read MoreVividion and Bayer Advance Oncology Pipeline with WRN Inhibitor
PrevNext
UK Biotech Day
Global Clinical
Global Clinical Trial Supply Forum 2026 I Frankfurt, Germany

About

The Pharma Data is an Information-Centric Website focused mainly on the Pharmaceutical Industry Online It is a B2B Platform mainly focused on the latest Pharmaceutical News, Press releases, Industry-related updates, Events, and Conferences. With The Pharma Data, you can get all the information that happening in the Pharmaceutical industry.

Advertise With Us: marketing@thepharmadata.com

Latest Posts

  • Ono Pharma Files Approval Application in Japan for Ripretinib in Advanced Gastrointestinal Stromal Tumor
  • Neurocrine Biosciences Unveils First Expert Consensus Guidelines for Tardive Dyskinesia in Long-Term Care Settings
  • Allergan Aesthetics Introduces Next-Generation JUVÉDERM Hyaluronic Acid Injectables at AMWC Monaco
  • About Us
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Contact Us

Copyright © 2026 | The Pharma Data | Marnet Technologies Pvt Ltd | All Rights Reserved.